HSE: No patients given at-risk chemo after recall

The HSE has said that no patient received potentially contaminated chemotherapy after it issued a recall last Monday.

Mon, 19 Oct, 2015 - 01:00

Evelyn Ring

The potentially contaminated chemotherapy was used in the treatment of cancer patients during the period October 2-9 only.

A cancer patient told RTÉ’s Liveline on Friday that she had been advised last Thursday that she might have been treated with contaminated product the previous day.

CONNECT WITH US TODAY

NEWSLETTERS

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

A male patient consults with a doctor about prostate cancer or some other disease.

Prostate cancer screening can lead to men facing unnecessary treatment, study finds

'It is sad for a fan of Eurovision': West Cork man says Irish fans support boycott of song contest

'Unfair gloss': RTÉ's Bakhurst grilled over reclassification of Derek Mooney and pay implications

Chemotherapy drug recall Place: Dublin Organisation: HSE Organisation: RTÉ Organisation: Fanning Compounding Organisation: Health Products Regulatory Authority Organisation: HPRA Organisation: Fannin Compounding Organisation: Irish Cancer Society

<p>Over 1,000 domestic abuse reports were made every week last year to gardaí</p>

1,000 domestic abuse reports made to gardaí every week last year

READ NOW

HSE: No patients given at-risk chemo after recall

1,000 domestic abuse reports made to gardaí every week last year

Lunchtime News

Latest

HSE: No patients given at-risk chemo after recall

Unlimited access starts here.

1,000 domestic abuse reports made to gardaí every week last year

Lunchtime News

Latest

Most Read